Medical treatments of neuron-related disorders are limited due to the difficulty of targeting brain cells. Major drawbacks are the presence of the blood-brain barrier and the lack of specificity of the drugs for the diseased cells. Nanomedicine-based approaches provide promising opportunities for overcoming these limitations. Although many previous reviews are focused on brain targeting with nanomedicines in general, none of those are concerned explicitly on the neurons, while targeting neuronal cells in central nervous diseases is now one of the biggest challenges in nanomedicine and neuroscience. We review the most relevant advances in nanomedicine design and strategies for neuronal drug delivery that might successfully bridge the gap between laboratory and bedside treatment in neurology.

Download full-text PDF

Source
http://dx.doi.org/10.2217/nnm-2020-0088DOI Listing

Publication Analysis

Top Keywords

overview nanomedicines
4
nanomedicines neuron
4
targeting
4
neuron targeting
4
targeting medical
4
medical treatments
4
treatments neuron-related
4
neuron-related disorders
4
disorders limited
4
limited difficulty
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!